Degradation of eukaryotic mRNAs plays an essential role in modulation of gene expression and in quality control of mRNA biogenesis. Deadenylation is the first major step in mammalian mRNA degradation and is often a rate-limiting step for mRNA decay and translational silencing, making it an important control point for both processes. Yet, the mechanisms by which deadenylation is regulated remain unknown. Mammalian deadenylation proceeds in two phases mediated consecutively by the Pan2-Pan3 and the Ccr4-Caf1 deadenylase complexes. Recent findings that Pan3 and Tob, two poly(A)-binding protein (PABP)-interacting proteins, modulate deadenylation suggest a new mode of gene regulation via changes in deadenylation, which helps cells reset their protein production profile. The importance of deadenylation in regulation of gene expression is further emphasized by recent observations. First, microRNAs (miRNAs) mediate rapid decay of their mRNA targets by accelerating deadenylation as a major route to gene silencing, though the underlying mechanisms and regulation remain largely unclear. Second, non-translatable mRNA-protein complexes (mRNPs) are found in RNA processing bodies (P-bodies), newly discovered cytoplasmic domains implicated in mRNA turnover, storage of non-translatable mRNPs, and translation repression. One major consequence of deadeny- lation is formation of non-translatable mRNPs, and we have shown that deadenylation is required for P- body formation in mammalian cells. It is plausible that deadenylation induces major mRNP remodeling that determines how mRNPs interact with the machinery mediating their subcellular localization, translation, or decay.
The specific aims of this proposal focus on addressing the following key questions: 1) What are the mechanisms by which deadenylation is regulated and how does the regulation of deadenylation affect the fate of mRNA?;2) What trans-acting factors are involved in miRNA-mediated deadenylation and decay and how is miRNA-mediated mRNA decay regulated?;and 3) What changes does deadenylation trigger in mRNA-protein or mRNP complexes and how do these changes influence an mRNP's fate? The proposed studies will reveal fundamental principles that govern mammalian mRNA turnover and provide crucial new mechanistic insights into several key issues related to the dynamic relationship between deadenylation, mRNA decay, translation and mRNP remodeling.

Public Health Relevance

The proposed studies will reveal fundamental principles that govern mammalian mRNA turnover and translation. Since many human diseases (e.g., cancers, autoimmune diseases, allergic inflammation, etc.) are associated with an alteration in the level of gene expression controlled by mRNA stability or translation, the proposed study has the potential to unravel new mechanisms underlying these conditions and thus facilitate the development of novel therapeutic agents.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Molecular Genetics C Study Section (MGC)
Program Officer
Bender, Michael T
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Health Science Center Houston
Schools of Medicine
United States
Zip Code
Masamha, Chioniso P; Xia, Zheng; Yang, Jingxuan et al. (2014) CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 510:412-6
Huang, Kai-Lieh; Chadee, Amanda B; Chen, Chyi-Ying A et al. (2013) Phosphorylation at intrinsically disordered regions of PAM2 motif-containing proteins modulates their interactions with PABPC1 and influences mRNA fate. RNA 19:295-305
Ezzeddine, Nader; Chen, Chyi-Ying A; Shyu, Ann-Bin (2012) Evidence providing new insights into TOB-promoted deadenylation and supporting a link between TOB's deadenylation-enhancing and antiproliferative activities. Mol Cell Biol 32:1089-98
Zheng, Dinghai; Chen, Chyi-Ying A; Shyu, Ann-Bin (2011) Unraveling regulation and new components of human P-bodies through a protein interaction framework and experimental validation. RNA 17:1619-34
Jones, Karlie; Jin, Bingwen; Iakova, Polina et al. (2011) RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2. Am J Pathol 179:2475-89
Chen, Frank; Shyu, Ann-Bin; Shneider, Benjamin L (2011) Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability. Hepatology 54:1371-8
Chen, Chyi-Ying A; Shyu, Ann-Bin (2011) Mechanisms of deadenylation-dependent decay. Wiley Interdiscip Rev RNA 2:167-83
Fabian, Marc R; Mathonnet, Geraldine; Sundermeier, Thomas et al. (2009) Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol Cell 35:868-80
Chen, Chyi-Ying A; Shyu, Ann-Bin (2009) HuD stimulates translation via eIF4A. Mol Cell 36:920-1
Mauxion, Fabienne; Chen, Chyi-Ying A; Seraphin, Bertrand et al. (2009) BTG/TOB factors impact deadenylases. Trends Biochem Sci 34:640-7

Showing the most recent 10 out of 22 publications